BigBearai Holdings Inc vs Novartis AG — how do they compare? BigBearai Holdings Inc trades at $3.35 (market cap $1.60B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 184.6× BigBearai Holdings Inc's market cap, and Novartis AG pays a 3.07% dividend while BigBearai Holdings Inc pays none. Which is the better fit depends on your goals.
| BBAI | NVS | |
|---|---|---|
Market Cap | $1.60B | $295.37B |
Sector | Technology | Health |
52-Week High | $8.91 | $168.62 |
52-Week Low | $2.61 | $119.31 |
Enterprise Value | $1.30B | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
BigBearai Holdings Inc is a specialized provider of AI-driven decision intelligence solutions, primarily serving the U.S. defense, intelligence, and national security communities. It operationalizes complex data into actionable insights through its core modules—Observe, Orient, and Dominate—to support mission-critical operations and logistics.
Read more on BBAI →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →